Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.56 |
| ▸ | GAA | P10253 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | GRK6 | P43250 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29851874 | 1.00 | MAPT (0.56) | MAPTKDM4EGAAMEN1KMT2A | |
| SCHEMBL17384923 | 0.90 | KDM4E (0.52) | MAPTKDM4EGAAMEN1KMT2A | |
| SCHEMBL29919897 | 0.87 | MAPT (0.43) | MAPTKDM4EGAAMEN1KMT2A | |
| SCHEMBL23457943 | 0.87 | MAPT (0.43) | MAPTKDM4EGAAMEN1KMT2A | |
| SCHEMBL14840186 | 0.82 | KDM4E (0.52) | MAPTKDM4EGAAALDH1A1TSHR | |
| SCHEMBL17365996 | 0.81 | MAPT (0.42) | MAPTKDM4EGAAMEN1KMT2A | |
| SCHEMBL1509318 | 0.79 | KDM4E (0.48) | MAPTKDM4EGAAALDH1A1TSHR | |
| SCHEMBL11517888 | 0.78 | TTR (0.44) | MAPTKDM4EGAAMEN1KMT2A | |
| N,N-Dimethylethanaminium SCHEMBL8487667 | 0.77 | KDM4E (0.78) | MAPTKDM4EGAAALDH1A1TSHR | |
| SCHEMBL29657743 | 0.77 | SIGMAR1 (0.54) | MAPTKDM4EMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11667731-B2 | Stabilized UV active organopalladium compounds as vinyl addition catalysts | PROMERUS, LLC (US) | 2023-06-06 | — | — | US | claimed |
| US-20230038665-A1 | STABILIZED UV ACTIVE ORGANOPALLADIUM COMPOUNDS AS VINYL ADDITON CATALYSTS | PROMERUS, LLC (US) | 2023-02-09 | — | — | US | claimed |
| US-20160233546-A1 | ELECTROLYTE SOLUTION AND LITHIUM ION BATTERIES USING THE SAME | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2016-08-11 | — | — | US | claimed |
| US-12510529-B2 | Method for determining authenticity and adulteration of marked petroleum hydrocarbons | SICPA HOLDING SA (CH) | 2025-12-30 | — | — | US | disclosed |
| EP-4069806-B1 | METHOD OF MARKING A PETROLEUM HYDROCARBON | SICPA HOLDING SA (CH) | 2025-04-16 | — | — | EP | disclosed |
| US-20240327736-A1 | METHOD OF MARKING A PETROLEUM HYDROCARBON | SICPA HOLDING SA (CH) | 2024-10-03 | — | — | US | disclosed |
| US-12031098-B2 | Method of marking a petroleum hydrocarbon | SICPA HOLDING SA (CH) | 2024-07-09 | — | — | US | disclosed |
| WO-2023248699-A1 | CATALYST NOBLE METAL PARTICLES | 株式会社キャタラー | 2023-12-28 | — | — | WO | disclosed |
| EP-4069807-B1 | METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS | SICPA HOLDING SA (CH) | 2023-10-04 | — | — | EP | disclosed |
| WO-2023158767-A1 | DUAL CATALYST SYSTEM FOR MASS VINYL ADDITION AND CATIONIC POLYMERIZABLE COMPOSITIONS | PROMERUS, LLC (US) | 2023-08-24 | — | — | WO | disclosed |
| US-20230265243-A1 | DUAL CATALYST SYSTEM FOR MASS VINYL ADDITION AND CATIONIC POLYMERIZABLE COMPOSITIONS | PROMERUS, LLC (US) | 2023-08-24 | — | — | US | disclosed |
| EP-0365053-B1 | Peroxide-curable brominated fluoroelastomer compositions | DU PONT (US) | 1994-05-04 | — | — | EP | disclosed |
| EP-0187893-B1 | PEROXIDE-CURABLE BROMINATED OR IODINATED FLUOROELASTOMER COMPOSITION CONTAINING AN N,N,N',N'-TETRASUBSTITUTED 1,8-DIAMINONAPHTHALENE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-07-25 | — | — | EP | disclosed |
| EP-0365053-A1 | Peroxide-curable brominated fluoroelastomer compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-04-25 | — | — | EP | disclosed |
| EP-0314480-A2 | Fluorescent indicator dyes for calcium working at long wavelengths | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1989-05-03 | — | — | EP | disclosed |
| EP-0208314-A2 | Fluorelastomers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-01-14 | — | — | EP | disclosed |
| US-4613636-A | IMPROVED DEMOLDING | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-09-23 | — | — | US | disclosed |
| EP-0187893-A2 | Peroxide-curable brominated or iodinated fluoroelastomer composition containing an N,N,N',N'-tetrasubstituted 1,8-diaminonaphthalene | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-07-23 | — | — | EP | disclosed |
| US-4529759-A | Polymer containing vinylidene fluoride | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-07-16 | — | — | US | disclosed |
| US-4029637-A | FIBERS | AKZONA INCORPORATED (US) | 1977-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12510529-B2 | Method for determining authenticity and adulteration of marked petroleum hydrocarbons | CYP4A11, CYP11B1, CYP11A1 | MAPT 4817/4885KDM4E 1686/4885GAA 4673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.